The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glofitamab monotherapy in pts with relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Extended follow-up and landmark analyses from a pivotal phase II study.
 
Lorenzo Falchi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Genmab; Roche/Genentech; Seagen
Research Funding - Genentech; Genmab; Roche
Travel, Accommodations, Expenses - Genmab
 
Carmelo Carlo-Stella
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene/Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Janssen Oncology; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Karyopharm Therapeutics; Novartis; Roche; Sanofi
Research Funding - ADC Therapeutics (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics; Janssen; Roche; Takeda
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; Genmab; Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Emmanuel Bachy
Honoraria - Amgen; Gilead Sciences; Incyte; Janssen-Cilag; Novartis; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Incyte; Novartis; Novartis; Roche; Takeda
Research Funding - Amgen Foundation (Inst); Bristol Myers Squibb Foundation (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Incyte; Janssen-Cilag; Roche
 
Guillaume Cartron
Honoraria - Abbvie; BMS; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - BMS; Mabqi; MedxCell; Roche
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Cyrus Khan
Honoraria - Abbvie; ADC Therapeutics; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Epizyme; Gilead Sciences; GlaxoSmithKline; Johnson & Johnson; Karyopharm Therapeutics; MorphoSys; Roche; Sanofi; Seagen
Consulting or Advisory Role - AstraZeneca; BeiGene; MorphoSys
Speakers' Bureau - Abbvie; ADC Therapeutics; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Epizyme; Gilead Sciences; GlaxoSmithKline; Johnson & Johnson; Karyopharm Therapeutics; MorphoSys; Roche; Sanofi; Seagen
Research Funding - AstraZeneca; BeiGene; Epizyme; Roche
Travel, Accommodations, Expenses - Abbvie; ADC Therapeutics; Amgen; AstraZeneca; BeiGene; BMS Brazil; Epizyme; Gilead Sciences; GlaxoSmithKline; Johnson & Johnson; Karyopharm Therapeutics; MorphoSys; Roche; Sanofi; Seagen
 
Monica Tani
Consulting or Advisory Role - Abbvie; Incyte; Kirin Pharmaceuticals
 
Joaquin Martinez-Lopez
Consulting or Advisory Role - BMSi; Janssen Oncology; Novartis
Speakers' Bureau - BMSi; Janssen-Cilag; Roche; Roche
Research Funding - Astellas Pharma (Inst); BMS (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - ADC Therapeutics; Foresight Diagnostics; Kite, a Gilead company; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene; Forty Seven (Inst); Janssen (Inst); Kite, a Gilead company; Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Antonio Salar
Speakers' Bureau - BeiGene; Bristol-Myers Squibb/Celgene; EUSA Pharma; Incyte; Janssen; Roche
Research Funding - Abbvie; Gilead Sciences; Roche
Travel, Accommodations, Expenses - Janssen; Roche
 
Joshua Brody
Consulting or Advisory Role - ADC Therapeutics; Epizyme; Genentech; Kite/Gilead; Merck; Seagen
 
Sirpa Leppä
Honoraria - Gilead Sciences; Incyte; Novartis
Consulting or Advisory Role - BeiGene; Gilead Sciences; Incyte; Novartis; Orion Clinical; Pfizer; Roche; SOBI
Research Funding - Bayer (Inst); Celgene (Inst); Genmab (Inst); Hutchison MediPharma (Inst); Novartis (Inst); Roche (Inst)
 
Estafania Mulvihill
Employment - Roche
Travel, Accommodations, Expenses - Roche
 
Linda Lundberg
Employment - Roche
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Roche
 
James Relf
Employment - Roche
Stock and Other Ownership Interests - F-Star Biotechnology; Harpoon therapeutics; Roche
 
Yuying Xie
Employment - Roche
 
Alessia Bottos
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Kathryn Humphrey
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Michael Dickinson
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Genmab; Gilead Sciences; Janssen; Novartis; Roche (I)
Research Funding - Abbvie (Inst); Celgene (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche